
Pipeline.
facilitating the development of endogenous treatment solutions
Endogenous solutions…
ENDO101
Our lead target harnesses the body’s ability to synthesize natural compounds that exert anxiolytic, antidepressant, and antiseizure effects.
ENDO201
Another lead compound similarly stimulates the body to synthesize endogenous compounds with a unique site of action in the brain and relevant for additional indications.
Priority Targets
Our pipeline is identifying additional targets to stimulate the synthesis of endogenous compounds with unique neuroactive functions. These are largely unexplored targets with undiscovered potential.